PTE Stock - PolarityTE, Inc.
Unlock GoAI Insights for PTE
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $814,000 | $9.40M | $10.13M | $5.65M | $1.56M |
| Gross Profit | $198,000 | $5.09M | $5.70M | $3.17M | $561,000 |
| Gross Margin | 24.3% | 54.1% | 56.3% | 56.1% | 35.9% |
| Operating Income | $-25,877,000 | $-32,378,000 | $-42,106,000 | $-93,393,000 | $-69,432,000 |
| Net Income | $10.21M | $-28,212,000 | $-43,922,000 | $-92,342,000 | $-65,441,000 |
| Net Margin | 1254.4% | -300.0% | -433.8% | -1633.8% | -4186.9% |
| EPS | $1.49 | $-8.81 | $-28.32 | $-92.47 | $-107.21 |
PolarityTE, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts, as well as contract research services. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; PTE 11000, an allogenic, biologically active dressing for use in wound care and aesthetics to accelerate healing of skin; and other tissue regeneration products. PolarityTE, Inc. is headquartered in Salt Lake City, Utah.
Visit WebsiteEarnings History & Surprises
PTEEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2024 | May 14, 2024 | — | — | — | — |
Q1 2024 | Mar 25, 2024 | — | — | — | — |
Q4 2023 | Nov 8, 2023 | — | — | — | — |
Q3 2023 | Aug 9, 2023 | $-0.55 | — | — | — |
Q2 2023 | Jun 12, 2023 | $-0.69 | $-2.50 | -262.3% | ✗ MISS |
Q1 2023 | Mar 27, 2023 | $0.83 | $-0.14 | -116.9% | ✗ MISS |
Q4 2022 | Nov 10, 2022 | $-1.21 | $-0.75 | +38.0% | ✓ BEAT |
Q3 2022 | Aug 11, 2022 | $-1.75 | $-1.30 | +25.7% | ✓ BEAT |
Q2 2022 | May 16, 2022 | $-2.00 | $-2.50 | -25.0% | ✗ MISS |
Q4 2021 | Dec 31, 2021 | — | $-0.10 | — | — |
Q4 2021 | Nov 10, 2021 | $-3.25 | $-2.25 | +30.8% | ✓ BEAT |
Q3 2021 | Aug 12, 2021 | $-3.00 | $-1.50 | +50.0% | ✓ BEAT |
Q2 2021 | May 13, 2021 | $-3.25 | $-3.00 | +7.7% | ✓ BEAT |
Q4 2020 | Dec 31, 2020 | — | $-0.26 | — | — |
Q4 2020 | Nov 9, 2020 | $-5.50 | $-4.50 | +18.2% | ✓ BEAT |
Q3 2020 | Aug 6, 2020 | $-10.00 | $-7.50 | +25.0% | ✓ BEAT |
Q2 2020 | May 11, 2020 | $-14.25 | $-13.25 | +7.0% | ✓ BEAT |
Q1 2020 | Mar 12, 2020 | $-23.00 | $-19.25 | +16.3% | ✓ BEAT |
Q4 2019 | Nov 12, 2019 | $-25.25 | $-21.75 | +13.9% | ✓ BEAT |
Q3 2019 | Aug 8, 2019 | $-26.50 | $-23.00 | +13.2% | ✓ BEAT |
Latest News
Frequently Asked Questions about PTE
What is PTE's current stock price?
What is the analyst price target for PTE?
What sector is PolarityTE, Inc. in?
What is PTE's market cap?
Does PTE pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to PTE for comparison